Blood collection at collection point
- You receive a test kit with tubes and referral letter
- Visit one of 800+ collection locations in the Netherlands
- Experienced staff professionally draw your blood
- Receive your results digitally by email
Aspergillus Antigen (Galactomannan)
Galactomannan antigen; early detection for those at risk.
€45.00EUR
€20.00EUR
€5.95EUR
Costs are per order
- TrustPilot 4.6/5 sterren
- No GP referral needed
- Reviewed by BIG-registered physician
- ISO 15189 Certified laboratory
- Results within 1 week
- Order today, ships today
What is the Aspergillus Antigen Galactomannan?
Galactomannan is a polysaccharide found in the cell wall of the fungus Aspergillus. It is a biomarker that can be detected in the blood of individuals infected with Aspergillus, a common fungal infection that can cause severe respiratory conditions and systemic infections, especially in people with a weakened immune system.
Why should you get tested for the Aspergillus Antigen Galactomannan?
This test is crucial for the early detection of Aspergillus infections, which is essential for initiating timely treatment to prevent severe complications. It is especially relevant for patients at increased risk of fungal infections, such as those with leukemia, bone marrow transplants, or individuals undergoing immunosuppressive therapy.
What does it indicate?
The presence of Galactomannan in the blood indicates an active Aspergillus infection. A positive test can assist in the diagnosis of invasive aspergillosis, a severe condition requiring immediate medical attention.
What does a high level of Aspergillus Antigen Galactomannan mean?
A high level of Galactomannan in the blood suggests a strong presence of Aspergillus fungi, indicating an active and possibly severe infection. This often requires immediate antifungal treatment.
What does a low level of Aspergillus Antigen Galactomannan mean?
A low or non-detectable level of Galactomannan may indicate that no active Aspergillus infection is present, or that the infection is under control for patients already undergoing treatment.
